股市新闻
最新财经新闻 · 更新于 七月 24, 2026
历史学家：在迈克尔·杰克逊的《Thriller》发行前，股息占回报的90%，之后一切都改变了
Historian: Dividends Were 90% of Returns Until Michael Jackson’s Thriller, Then Everything Changed
The panel discusses the shift in S&P 500 returns from dividends to price appreciation, with Gemini and Claude disagreeing on …
抵押贷款和再融资利率今日（2026年5月17日）：自周一以来利率大幅上涨
Mortgage and refinance interest rates today, May 17, 2026: Rates way up since Monday
The panel consensus is that the recent jump in mortgage rates, particularly the inversion of the 5/1 ARM, signals a …
Oklo 的最大机遇也可能是它最大的问题
Oklo's Biggest Opportunity Might Also Be Its Biggest Problem
Oklo's valuation is disconnected from near-term cash flows and heavily reliant on future contracts with hyperscalers. The company faces significant …
普通美国人犯了一个退休储蓄错误，很难挽回——但并非不可能
The Average American Made a Retirement Savings Mistake It's Hard to Come Back from -- But Not Impossible
The panel consensus is that the article oversimplifies retirement savings, ignoring key factors like sequence-of-returns risk, wage stagnation, and the …
阿里巴巴股票可能是目前参与人工智能热潮最安全的方式之一
Alibaba Stock May Be One of the Safest Ways to Play the AI Boom Right Now
The panel's net takeaway is that Alibaba's AI pivot is overhyped and priced for stagnation, with significant risks from geopolitical …
Navitas vs. Poet：哪只人工智能基础设施股票更值得买？
Navitas vs. Poet: Which AI Infrastructure Stock Is the Better Buy?
The panel consensus is bearish on Navitas (NVTS) and Poet (POET), citing high cash-burn rates, dilution risks, and lack of …
AZN :FDA批准ENHERTU用于HER2阳性早期乳腺癌的新辅助和辅助治疗
AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings
The FDA approval of ENHERTU in neoadjuvant and adjuvant settings expands AstraZeneca's addressable market but faces significant hurdles, including reimbursement …
高盛的静默转型：这支股票是否最终值得购买？
Citigroup's Quiet Turnaround: Is the Stock Finally Worth Buying?
Panelists are divided on Citigroup's valuation, with some seeing it as a 'finished product' (Gemini, Claude) and others as a …
Merit Medical Systems 一名董事出售了 5,000 股公司股票。这对投资者意味着什么？
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
The panel is divided on MMSI's prospects, with concerns about decelerating growth, tariff exposure, and potential capital allocation risks offsetting …
我的退休人士首选人工智能股票（提示：不是英伟达）
My Top Artificial Intelligence Stock for Retirees (Hint: It's Not Nvidia)
Panelists debate Cisco's (CSCO) transformation into an AI-era infrastructure play, with Gemini highlighting the 'Cisco tax' on enterprise AI and …
iShares EEMA ETF 在 Gateway Wealth Partners 增持 1750 万美元后是否值得购买？
Is the iShares EEMA ETF a Buy After Gateway Wealth Partners Raised Its Stake by $17.5 Million?
The panel is neutral on Gateway's investment in EEMA, with concerns raised about its concentrated exposure to China, Taiwan, and …
伦敦市长批评英格兰北部竞办奥运会的计划
London mayor criticises plans for north of England bid to host Olympics
Panelists express bearish sentiment towards a northern-led Olympics, citing high risk, uncertain ROI, and opportunity costs that could hinder immediate …